Innate immune reprogramming to overcome therapy resistance in high-risk colorectal cancer
Dauer: 36 Monate, Fördersumme: € 800.000
Precision medicine for breast cancer: multi-omics towards predicting complete remission and avoiding surgery
Dauer: 48 Monate, Fördersumme: € 899.630
Decoding cellular senescence in glioblastoma (GlioAge)
Dauer: 36 Monate, Fördersumme: € 898.970